Published in J Inherit Metab Dis on April 14, 2015
Quick Diagnosis of Alkaptonuria by Homogentisic Acid Determination in Urine Paper Spots. JIMD Rep (2016) 0.75
Angiogenesis in alkaptonuria. J Inherit Metab Dis (2016) 0.75
Acute fatal metabolic complications in alkaptonuria. J Inherit Metab Dis (2015) 0.75
Natural history and outcome in systemic AA amyloidosis. N Engl J Med (2007) 4.54
Functional amyloid formation within mammalian tissue. PLoS Biol (2006) 3.92
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol (2012) 3.03
Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med (2002) 2.35
The probable involvement of soluble and deposited melanins, their intermediates and the reactive oxygen side-products in human diseases and aging. Toxicology (2000) 1.62
Rare-disease project has global ambitions. Nature (2011) 1.51
Development of an in vitro model to investigate joint ochronosis in alkaptonuria. Rheumatology (Oxford) (2010) 1.28
An update on molecular genetics of Alkaptonuria (AKU). J Inherit Metab Dis (2011) 1.18
Arthroplasty for ochronotic arthritis: no failure of 11 replacements in 3 patients followed 6-12 years. Acta Orthop Scand (2004) 1.18
Alkaptonuria--a review of surgical and autopsy pathology. Histopathology (2008) 1.16
Chronic ochronotic arthritis: clinical, arthroscopic, and pathologic findings. J Rheumatol (2000) 1.11
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. Rheumatology (Oxford) (2010) 1.11
Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview. Arthritis Rheum (2009) 1.10
Alkaptonuria is a novel human secondary amyloidogenic disease. Biochim Biophys Acta (2012) 1.09
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol (2010) 1.06
BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells. Proc Natl Acad Sci U S A (2013) 1.04
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. J Cell Physiol (2012) 1.04
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes. J Cell Biochem (2010) 1.03
Segmental polymorphism in a functional amyloid. Biophys J (2011) 1.01
Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis. FEBS Lett (2009) 1.01
Biochemical and proteomic characterization of alkaptonuric chondrocytes. J Cell Physiol (2012) 0.99
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. Rheumatology (Oxford) (2013) 0.98
Ultrastructural examination of tissue in a patient with alkaptonuric arthropathy reveals a distinct pattern of binding of ochronotic pigment. Rheumatology (Oxford) (2010) 0.98
PMEL: a pigment cell-specific model for functional amyloid formation. Pigment Cell Melanoma Res (2013) 0.97
Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis. J Inherit Metab Dis (2011) 0.96
Homogentisic acid autoxidation and oxygen radical generation: implications for the etiology of alkaptonuric arthritis. Free Radic Biol Med (1987) 0.94
Critical residues in the PMEL/Pmel17 N-terminus direct the hierarchical assembly of melanosomal fibrils. Mol Biol Cell (2013) 0.91
A novel ex vivo organotypic culture model of alkaptonuria-ochronosis. Clin Exp Rheumatol (2011) 0.91
The yin and yang of amyloid: insights from α-synuclein and repeat domain of Pmel17. Phys Chem Chem Phys (2011) 0.90
A new role for chondrocytes as non-professional phagocytes. An in vitro study. Microsc Res Tech (2004) 0.84
Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient. Mediators Inflamm (2014) 0.83
Amyloid A amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatments. Clin Exp Rheumatol (2011) 0.82
The PKD domain distinguishes the trafficking and amyloidogenic properties of the pigment cell protein PMEL and its homologue GPNMB. Pigment Cell Melanoma Res (2013) 0.81
Interferences of homogentisic acid (HGA) on routine clinical chemistry assays in serum and urine and the implications for biochemical monitoring of patients with alkaptonuria. Clin Biochem (2013) 0.81
Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model. Amyloid (2007) 0.81
Chondrocyte of rheumatoid arthritis serve as a source of intra-articular acute-phase serum amyloid A protein. Clin Chim Acta (2008) 0.79
Secondary amyloidosis in an alkaptonuric aortic valve. Int J Cardiol (2014) 0.79
Lysophospholipid-containing membranes modulate the fibril formation of the repeat domain of a human functional amyloid, pmel17. J Mol Biol (2014) 0.79
Chondroptosis in alkaptonuric cartilage. J Cell Physiol (2015) 0.78
Protein thiolation index (PTI) as a biomarker of oxidative stress. Free Radic Biol Med (2012) 0.78
Oxidative stress and mechanisms of ochronosis in alkaptonuria. Free Radic Biol Med (2015) 0.78
[Parkinson disease and alkaptonuria: fortuitous association or striatonigral ochronosis?]. Rev Neurol (Paris) (1995) 0.76
Immunolocalization of lipid peroxidation/advanced glycation end products in amyloid A amyloidosis. Free Radic Biol Med (2004) 0.76
Redox proteomics gives insights into the role of oxidative stress in alkaptonuria. Expert Rev Proteomics (2013) 0.76
Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria. J Inherit Metab Dis (2015) 0.76
Diagnosis of secondary amyloidosis in alkaptonuria. Diagn Pathol (2014) 0.75
[Biogenesis of melanosomes - the chessboard of pigmentation]. Med Sci (Paris) (2011) 0.75
Amyloid A deposition in rheumatoid arthritis: a retrospective clinicopathologic study of 161 autopsy patients. Amyloid (2012) 0.75
False proteinuria in patients with alkaptonuria. Clin Exp Rheumatol (2010) 0.75
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet (2008) 7.37
ER-to-Golgi carriers arise through direct en bloc protrusion and multistage maturation of specialized ER exit domains. Dev Cell (2003) 1.71
Electron-tomographic analysis of intraflagellar transport particle trains in situ. J Cell Biol (2009) 1.56
Development of an in vitro model to investigate joint ochronosis in alkaptonuria. Rheumatology (Oxford) (2010) 1.28
Cryoelectron tomography of radial spokes in cilia and flagella. J Cell Biol (2011) 1.17
F-actin dynamics control segregation of the TCR signaling cascade to clustered lipid rafts. Eur J Immunol (2002) 1.14
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. Rheumatology (Oxford) (2010) 1.11
Extragastric manifestations of Helicobacter pylori infection. Helicobacter (2010) 1.11
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer (2009) 1.10
Alkaptonuria is a novel human secondary amyloidogenic disease. Biochim Biophys Acta (2012) 1.09
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem (2009) 1.09
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol (2010) 1.06
Antimicrobial activity against Helicobacter pylori strains and antioxidant properties of blackberry leaves (Rubus ulmifolius) and isolated compounds. Int J Antimicrob Agents (2009) 1.06
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. J Cell Physiol (2012) 1.04
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes. J Cell Biochem (2010) 1.03
Helicobacter pylori toxin VacA is transferred to host cells via a novel contact-dependent mechanism. Cell Microbiol (2004) 1.01
Biochemical and proteomic characterization of alkaptonuric chondrocytes. J Cell Physiol (2012) 0.99
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. Rheumatology (Oxford) (2013) 0.98
A proteomic study on human osteoblastic cells proliferation and differentiation. Proteomics (2006) 0.98
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis (2002) 0.97
Proteomic response to physiological fermentation stresses in a wild-type wine strain of Saccharomyces cerevisiae. Biochem J (2003) 0.96
GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence. Infect Immun (2004) 0.96
Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis. J Inherit Metab Dis (2011) 0.96
Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients. Clin Rev Allergy Immunol (2012) 0.94
Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.92
Proteome analysis of Neisseria meningitidis serogroup A. Proteomics (2004) 0.92
Isomin: a novel cytoplasmic intermediate filament protein from an arthropod species. BMC Biol (2011) 0.91
The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. Immunobiology (2005) 0.89
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells. FASEB J (2008) 0.88
A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype. Infect Immun (2006) 0.87
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis. Helicobacter (2007) 0.87
Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice. J Med Chem (2007) 0.87
Comparative analysis of the effects of locally used herbicides and their active ingredients on a wild-type wine Saccharomyces cerevisiae strain. J Agric Food Chem (2006) 0.86
Rapid aggregation and assembly in aqueous solution of A beta (25-35) peptide. J Biosci (2009) 0.85
Long-term effects of neridronate on human osteoblastic cell cultures. Bone (2004) 0.85
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors. Eur J Med Chem (2010) 0.85
Western blotting of total lysate of Helicobacter pylori in cases of atrophic body gastritis. Clin Chem (2005) 0.84
Post-genomics of bone metabolic dysfunctions and neoplasias. Proteomics (2012) 0.84
Immonium ion scanning for the discovery of post-translational modifications and its application to histones. J Proteome Res (2008) 0.84
The organization of the wall filaments and characterization of the matrix structures of Toxoplasma gondii cyst form. Cell Microbiol (2011) 0.83
Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli. Proteomics (2002) 0.83
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. Proteomics (2005) 0.83
Two-step elution of human serum proteins from different glass-modified bioactive surfaces: a comparative proteomic analysis of adsorption patterns. Electrophoresis (2004) 0.83
Simultaneous alignment of dual-axis tilt series. J Struct Biol (2009) 0.82
The analysis of Neisseria meningitidis proteomes: Reference maps and their applications. Proteomics (2007) 0.82
Crystalloid body, refractile body and virus-like particles in Apicomplexa: what is in there? Parasitology (2012) 0.81
Membrane specializations in the spermatozoa of collembolan insects. J Struct Biol (2003) 0.81
Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases. Isr Med Assoc J (2008) 0.81
Postgenomics of Neisseria meningitidis: an update. Expert Rev Proteomics (2009) 0.81
The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology. Pediatr Allergy Immunol (2011) 0.81
Establishment and characterization of 4 new human pancreatic cancer cell lines: evidences of different tumor phenotypes. Pancreas (2009) 0.81
Postgenomics of Neisseria meningitidis for vaccines development. Expert Rev Proteomics (2007) 0.80
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure. PLoS One (2011) 0.80
Proteomics and redox-proteomics of the effects of herbicides on a wild-type wine Saccharomyces cerevisiae strain. J Proteome Res (2009) 0.80
Unusual axonemes of hexapod spermatozoa. Int Rev Cytol (2006) 0.80
Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients. Clin Rev Allergy Immunol (2013) 0.80
The fine structure of the Acanthamoeba polyphaga cyst wall. FEMS Microbiol Lett (2010) 0.80
Isolation of intraflagellar transport trains. Cytoskeleton (Hoboken) (2013) 0.79
Helicobacter pylori: immunoproteomics related to different pathologies. Expert Rev Proteomics (2007) 0.79
Linking protein oxidation to environmental pollutants: redox proteomic approaches. J Proteomics (2011) 0.79
Chondroptosis in alkaptonuric cartilage. J Cell Physiol (2015) 0.78
Small HDL form via apo A-I a complex with atrial natriuretic peptide. Biochem Biophys Res Commun (2004) 0.78
Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype. Expert Rev Proteomics (2010) 0.78
External gestation of Exogone naidina Oersted, 1845 (Polychaeta, Syllidae): ventral attachment of eggs and embryos. Tissue Cell (2003) 0.78